上海富雨生物科技有限公司
初級(jí)會(huì)員 | 第1年

18956075901

當(dāng)前位置:上海富雨生物科技有限公司>>細(xì)胞庫(kù) / 細(xì)胞培養(yǎng)>>干細(xì)胞>> HRVEC人視網(wǎng)膜微血管內(nèi)皮細(xì)

HRVEC人視網(wǎng)膜微血管內(nèi)皮細(xì)

參  考  價(jià)面議
具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號(hào)

品       牌

廠商性質(zhì)生產(chǎn)商

所  在  地

更新時(shí)間:2025-02-11 17:12:03瀏覽次數(shù):26次

聯(lián)系我時(shí),請(qǐng)告知來自 化工儀器網(wǎng)
同類優(yōu)質(zhì)產(chǎn)品更多>
HRVEC人視網(wǎng)膜微血管內(nèi)皮細(xì)胞CatalogueNo

HRVEC 人視網(wǎng)膜微血管內(nèi)皮細(xì)胞
Catalogue No.: C1165
Product Format: a T25 flask
Culture Properties貼壁
Complete Growth Medium: 89%H-DMEM+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.

Components

Item Specifications
a T25 flask 2X106
Manual 1 copy



group is controlled by the exact probability method, and the Pss18.0 system is used to test the hypothesis of survival rate comparison. The experimental results showed that the tumor inhibition rate in this group was 65.8%. Compared with the 5-FU group and model group, the dose group has shown an antitumor effect and had significantly improved the tumor-bearing body's antitumor red blood cell immune function and tumor cell


會(huì)員登錄

×

請(qǐng)輸入賬號(hào)

請(qǐng)輸入密碼

=

請(qǐng)輸驗(yàn)證碼

收藏該商鋪

X
該信息已收藏!
標(biāo)簽:
保存成功

(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

常用:

提示

X
您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~
撥打電話
在線留言